Clinical Trials Browser

Carcinoma, Ovarian Epithelial, Adenocarcinoma, Bile Duct Neoplasms, Biliary Tract Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Transitional Cell, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Carcinoma, Small Cell, Carcinoma, Ductal, Small Cell Lung Carcinoma, Inflammatory Breast Neoplasms

NCT05099978 2024-09-04

A-TRAIN

Unknown

506 enrolled

BreastGynecologicHead & Neck

Nasopharyngeal Carcinoma, Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT06256055 2024-07-24

Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors

Phase 1 Unknown

24 enrolled

GastrointestinalGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Bile Duct Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT05989724 2024-04-24

A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

Phase 1 Unknown

150 enrolled

BreastGastrointestinalGynecologic

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

Clinical Trials

CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors

A-TRAIN

Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors

A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

Fasting Mimicking Diet in Chemotherapy of Gynecologic Malignancies

Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis

STILVARCA

A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian Cancer

Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors

PANO

The Epigenetic Regulatory Role of P-element Induced Wimpy Testis (Piwi) Interacting RNA-823 (piR-823) in Ovarian Cancer Progression

Artificial Intelligence Model for Growth Prediction of Ovarian Cancer Organoids

Pemb-HT

BRCA 1/2 Status as a Predictive Factor to Response to Platinum Based Chemotherapy in Cancer Ovary

Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors

DCE-MRI

PITHAC

Preventing Ovarian Cancer Through Oportunistic Salpingectomy at the Time of Colorectal Surgery

Family History Study on Cancer Risk

The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1

BENITA

Dalpiciclib Combined With Letrozole in HR+/HER2 - Gynecologic Solid Tumors

Lenvatinib Plus Toripalimab for Platinum-Resistant Recurrent Ovarian Cancer

HER2 Expression in Gynecological Malignant Tumors in Chongqing Area of China

STOPOVCA

ERASGYNBS002

SUROVA

Study on Symptom Clusters During Chemotherapy in Ovarian Cancer Patients With Different Chinese Medicine Constitution

NEO

Using Genetic Profile to Determine the Treatment for Patients With Ovarian Cancer Who Previously Received a PARP-inhibitor

IMMUNOPARP

Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARPi

OPTI-DOSE

Predictors of Ovarian Cancer and Endometrial Cancer for Artificial-Intelligence-Based Screening Tools

Sirius in Gynaecological Laparoscopic Surgery

MIRRORS-RCTP

MITO-8

AL3818

New Prognostic Index for Neoadjuvant Chemotherapy Outcome in Patients With Advanced High-grade Serous Ovarian Cancer

Doppler Ultrasound and CT Versus Laparoscopy in Assessment of Ovarian Malignancy

AMT-151 in Patients With Selected Advanced Solid Tumours

Oral Minoxidil for the Treatment of Recurrent Platinum Resistant Epithelial Ovarian Cancer

IMX-110 in Patients With Advanced Solid Tumors

Factors Affecting the Prognosis of Early Ovarian Cancer

A Real-World Patient-Reported Outcomes Study in Patients With Long-Term Use of Niraparib

Dynamic Monitoring of ctDNA Predicts Recurrence of Advanced Ovarian Cancer After Primary Treatments

The Culture of Ovarian Cancer Organoids and Drug Screening

The Culture of Advanced or Recurrent Ovarian Cancer Organoids and Drug Screening

A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T